Explanatory Note
Explanatory Note
Xxxxxx Xxxxxxx Laboratories, Inc. has prepared this Form 1-A/A solely for the purpose of filing Exhibits 11.1 and 12.1.
Part III
EXHIBITS
*Filed herewith.
**Filed as an exhibit to Xxxxxx Xxxxxxx Laboratories, Inc. Regulation A Offering Statement on Form 1-A (Commission File No. 024-11229) and incorporated herein by reference. Available at, xxxxx://xxx.xxx.xxx/Xxxxxxxx/xxxxx/xxxx/0000000/000000000000000000/0000000000-00-000000-xxxxx.xxx.
***Filed as an exhibit to Xxxxxx Xxxxxxx Laboratories, Inc. Regulation A Offering Statement on Form 1-A (Commission File No. 024-11229) and incorporated herein by reference. Available at, xxxxx://xxx.xxx.xxx/Xxxxxxxx/xxxxx/xxxx/0000000/000000000000000000/xx0000000x0_xxxxxxxxxxxx.xxx.
Pursuant to the requirements of Regulation A, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this Offering Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on August 10, 2020.
XXXXXX XXXXXXX LABORATORIES INC.
By | /s/ Xxxxx Xxxxx | |
Xxxxx Xxxxx, Chief Executive Officer, Principal Executive Officer and Director |
/s/ Xxxxxxx X. Xxxxxx |
|
Xxxxxxx X. Xxxxxx, Chief Financial Officer, | |
Principal Financial Officer, Principal Accounting Officer and Director |